Influence of Immunosuppression and Effect of Hepatitis C Virus on New Onset of Diabetes Mellitus in Liver Transplant Recipients
✍ Scribed by B. Sánchez-Pérez; J.M. Aranda Narváez; J. Santoyo Santoyo; J.L. Fernández-Aguilar; M.A. Suárez Muñoz; A.J. González-Sánchez; J.A. Pérez Daga; C.P. Ramírez Plaza; J. Carrasco Campos; C. Jiménez Mazure; R. Becerra Ortíz
- Book ID
- 116934746
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 114 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
New-onset diabetes mellitus (NODM) is seen in 10-30% of renal and 9-21% of liver transplant recipients. [1][2][3][4][5][6][7][8][9][10][11][12][13][14] Older age, black race, obesity, hepatitis C virus (HCV) infection, family history of diabetes mellitus (DM), and use of tacrolimus or corticosteroid
Epidemiological studies suggest diabetes mellitus (DM) may be an extrahepatic manifestation of chronic hepatitis C virus (HCV) infection. Since diabetes and HCV are common in liver transplant recipients, we sought to examine the unique contribution of HCV infection to risk of de novo diabetes posttr